new delhi: The developer of the country’s first Indigenous surgical robotic technology, SS Innovations, the visionary force behind Made-in-India SSI Mantra Surgical Robotic System, has achieved another historic feat. It became the first and only company in India to receive a Central Drugs Standard Control Organization (CDSCO) regulatory approval for telesurgery and teleproctoring, signifying a monumental leap in surgical robotics.
With this, SSI Mantra has the first surgical robotic system in India authorised to perform such advanced capabilities. It paves the way for SS Innovations’ commitment to advancing surgical technology, making cutting-edge procedures more accessible and reinforcing the position of India as a global leader in healthcare innovation. It aims to decentralise access to surgical expertise.